Compass Pathways PLC (CMPS)
7.89
-0.10
(-1.25%)
USD |
NASDAQ |
May 17, 16:00
7.79
-0.10
(-1.27%)
After-Hours: 20:00
Compass Pathways Total Liabilities (Quarterly): 49.83M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 49.83M |
| December 31, 2023 | 50.24M |
| September 30, 2023 | 45.78M |
| June 30, 2023 | 43.44M |
| March 31, 2023 | 11.67M |
| December 31, 2022 | 16.01M |
| September 30, 2022 | 29.96M |
| June 30, 2022 | 14.05M |
| March 31, 2022 | 12.52M |
| Date | Value |
|---|---|
| December 31, 2021 | 16.49M |
| September 30, 2021 | 9.323M |
| June 30, 2021 | 7.801M |
| March 31, 2021 | 7.639M |
| December 31, 2020 | 6.895M |
| September 30, 2020 | 4.92M |
| June 30, 2020 | 121.93M |
| December 31, 2019 | 62.78M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
4.92M
Minimum
Sep 2020
121.93M
Maximum
Jun 2020
30.08M
Average
16.01M
Median
Dec 2022
Total Liabilities (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 233.64M |
| Biodexa Pharmaceuticals Plc | 7.470M |
| Verona Pharma PLC | 64.92M |
| NuCana PLC | 16.46M |
| Autolus Therapeutics PLC | 263.91M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 308.99M |
| Shareholders Equity (Quarterly) | 259.16M |